mardi 13 décembre 2016

Onco Actu du 13 décembre 2016


3.1 Tabac

Marijuana is now more popular among teens than tobacco or e-cigarettes [STAT]

3.1.1 Tabac - e-cigs

E-cigarette use falls among teens for the first time, study finds [LA Times]

5. Traitements

Drug combinations that help breast cancer patients discovered using data science [Stanford Medicine]

5.12 Immunothérapies

BMS' Opdivo jumps back into pharma's top 3 TV ad spenders for November [FiercePharma]

Pfizer bankrolls an oncolytics biotech upstart with an eye on a future buyout [EndPoints]

5.12.2 Immunothérapies - CAR-T

Kite Pharma Announces Publication of T-Cell Therapy Targeting Mutant KRAS in Cancer by the National Cancer Institute (NCI) in New England Journal of Medicine [Kite]

5.2 Pharma

Seattle Genetics chalks up first clinical trial success in solid tumors [FierceBiotech]

5.2.3 Pharma - économie

Supreme Court declines to hear biologic drug patent fight [Reuters]

5.3 Traitements - FDA, EMA, NICE...

Scottish Medicines Consortium approves Sanofi's prostate cancer drug [Pharmafile]

Faster Information from FDA Means Improved Drug Safety for Patients [FDA Voice]

5.4 Traitements - Economie

Once-spurned cancer drugs win NICE's favor with—no surprise—'sensible pricing' [FiercePharma]

Scottish breast cancer patients denied drug approved for English NHS [The Telegraph]

5.7.1 SABCS-communiqués

Interim Results from Phase 1b/2 Study Evaluating the Combination of Merck’s KEYTRUDA® (pembrolizumab) and Eisai’s HALAVEN® (eribulin mesylate) Injection in Metastatic Triple-Negative Breast Cancer Presented at 2016 SABCS [Merck]

5.7.2 SABCS-divers

Untreated Late Effects of Breast Cancer Care Increase Depression and Anxiety Among Survivors, Penn Study Shows [Penn Medicine]

5.9 AACR

AACR Receives $1.125 Million NCI Grant to Continue Clinical Trials Workshop [AACR]

6.1 Observation

Social support tied to better breast cancer outcomes [Reuters]

6.10.1 Politiques (USA)

Trump is considering a radical to lead FDA. That’s dangerous for public health [STAT]

6.6 Publications

Dear peer reviewer, you stole my paper: An author’s worst nightmare [Retraction Watch]

6.7 DMP, Big Data & applis

Watson and Pfizer [In the Pipeline]